Blood Test Could Signal Future Risk of Severe Respiratory Conditions
The experimental blood test analyzes 32 proteins to predict an individual's risk of developing severe lung diseases like COPD, offering potential for earlier intervention.
Tag: NIH/NIAID
All
Latest
All
Latest
COVID-19 Reinfection Severity Linked to Initial Case
An NIH-funded study finds those with severe initial COVID-19 infections are more likely to experience severe symptoms upon reinfection.
All
Latest
Acetaminophen Reduces Organ Injury and ARDS in Sepsis Patients
In patients most at risk for organ damage, the drug lessened the need for assisted ventilation and showed a slight decrease in mortality.
NIH Scientists Identify Key Antibodies Targeting Elusive Part of Flu Virus
The discovery shows that the “dark side” of influenza virus protein has unique, previously untapped epitopes that could be applied to the development of new vaccine and treatment strategies.
Read More
NIH Launches Trials on Three Potential Treatments for Long COVID
Two phase 2 trials will evaluate the safety and effectiveness of the therapies for symptoms such as fast heart rate, dizziness, and fatigue.
Read More
$3M Grant Awarded to Develop New Therapies for Lung Diseases in Preemies
The NIH grant will support the development of new treatment methods for lung diseases in premature infants using gene and cell therapy.
Read More
Cannabis Smoking Raises Heart Attack and Stroke Risk
Daily use was associated with a 25% increased likelihood of heart attack and a 42% increased likelihood of stroke.
Read More
Two-Thirds of Children Tolerate Peanut Protein After Omalizumab Treatment
The treatment yielded similar outcomes for egg, milk, wheat, cashew, walnut, and hazelnut.
Read More
Blood Test Can Quickly Diagnose Sarcoidosis
Researchers have developed a tool to rapidly and inexpensively diagnose sarcoidosis using a simple blood test.
Read More
COVID-19 Vaccines in Pregnancy Shield Infants for Six Months
An NIH study found that women who receive an mRNA-based COVID-19 vaccination or booster during pregnancy can provide their infants with strong protection against symptomatic COVID-19 infection for at least six months after birth.
Read More
Sequential Flu and Measles-like Virus Infections Trigger Deadly Lung Failure
Georgia State University researchers discover that ferrets recovering from flu-like viruses suffer lethal lung damage when subsequently infected with a measles-like virus.
Read More
$9M NIH Grant Fuels Progress of Novel Smoking Cessation Drug
Funding awarded to scientists at Camino Pharma, Sanford Burnham Prebys, and UC San Diego will expand the nonclinical studies to support a phase 2 clinical evaluation of SBP-9330.
Read More
Higher Ventilator Mortality in Rural Intermediate Care Units
Patients receiving ventilator life support in rural hospital intermediate care units had significantly higher death rates than patients in the same type of unit at urban hospitals.
Read More
Omalizumab Reduces Allergic Reactions to Multiple Foods in Youth
The monoclonal antibody treatment significantly increased the amounts of multiple common foods that food-allergic children and adolescents could consume.
Read More
Federal Home Testing Program Expands Nationwide, Adding Flu Services
The federal government has expanded the Home Test to Treat program, a virtual health program offering free COVID-19—and now influenza—health services to eligible participants nationwide.
Read More